Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors
Clinical trial NCT05450562 · TERMINATED
Trial details
- NCT number
- NCT05450562
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-20
- Primary completion
- 2025-12-22
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.